Therapy Areas
24 September 2021 - - US-based synthetic biology and genomics company Twist Bioscience Corp's (NASDAQ: TWST) internally-discovered antibody candidate TB202-3 (CoVIC-094), demonstrated potent binding to diverse SARS-CoV-2 variant mutations, inclu...
24 September 2021 - - An independent Data Safety Monitoring Board has completed its prespecified interim analysis data review of the safety and efficacy of SAB-185 in the Phase 2 portion of the ACTIV-2 trial and has recommended advancement to Phase 3...
24 September 2021 - - US-based biotechnology and pharmaceutical company Reven Holdings, Inc has completed Part 1 of the Two-Part, Two Cohort Multi-Center Phase I/II trial of Reven's lead anti-sepsis drug candidate RJX in hospitalized high-risk C...
24 September 2021 - - Dr. Mikael Dolsten, chief scientific officer and president, Worldwide Research, Development and Medical, Pfizer Inc. has been elected to US-based Agilent Technologies, Inc's (NYSE: A) board of directors, the company said.
24 September 2021 - - US-based pharmacy operator Walgreens is offering eligible individuals in the US the Pfizer COVID-19 booster vaccinations in stores nationwide, following Food and Drug Administration Emergency Use Authorization and new guidance f...
24 September 2021 - - US-based biotechnology company Pulmotect, Inc has posted positive topline results from the first of two Phase-2 clinical trials undertaken with the support of the US Department of Defense to evaluate PUL-042 against COVID-19, th...
24 September 2021 - - US-based biotechnology company Moderna, Inc. (NASDAQ: MRNA) has inked a supply agreement with the government of Peru for 20 m doses of Moderna's COVID-19 vaccine to begin delivery in the first quarter of 2022, the comp...